Tom Foltynie, Dilan Athauda. Prog Brain Res 2020
Times Cited: 18
Times Cited: 18
Seung Pil Yun, Tae-In Kam, Nikhil Panicker, SangMin Kim, Yumin Oh, Jong-Sung Park, Seung-Hwan Kwon, Yong Joo Park, Senthilkumar S Karuppagounder, Hyejin Park, Sangjune Kim, Nayeon Oh, Nayoung Alice Kim, Saebom Lee, Saurav Brahmachari, Xiaobo Mao, Jun Hee Lee, Manoj Kumar, Daniel An, Sung-Ung Kang, Yunjong Lee, Kang Choon Lee, Dong Hee Na, Donghoon Kim, Sang Hun Lee, Viktor V Roschke, Shane A Liddelow, Zoltan Mari, Ben A Barres, Valina L Dawson, Seulki Lee, Ted M Dawson, Han Seok Ko. Nat Med 2018
Times Cited: 458
Times Cited: 458
List of shared articles
Times cited
Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer's and Parkinson's diseases.
Christian Hölscher. Front Synaptic Neurosci 2022
Christian Hölscher. Front Synaptic Neurosci 2022
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Juris J Meier. Mol Metab 2021
Michael A Nauck, Daniel R Quast, Jakob Wefers, Juris J Meier. Mol Metab 2021
L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease.
Osama F Elabi, Jeffrey S Davies, Emma L Lane. Int J Mol Sci 2021
Osama F Elabi, Jeffrey S Davies, Emma L Lane. Int J Mol Sci 2021
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment.
Katherine O Kopp, Elliot J Glotfelty, Yazhou Li, Nigel H Greig. Pharmacol Res 2022
Katherine O Kopp, Elliot J Glotfelty, Yazhou Li, Nigel H Greig. Pharmacol Res 2022
Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's disease.
Xiaoyan Yang, Peng Feng, Rong Ji, Yiqing Ren, Wenshi Wei, Christian Hölscher. Expert Opin Ther Targets 2022
Xiaoyan Yang, Peng Feng, Rong Ji, Yiqing Ren, Wenshi Wei, Christian Hölscher. Expert Opin Ther Targets 2022